Zydus Cadila Needle-Free Vaccine ZyCoV D after testing has been approved for use in India. The special point about this vaccine is that it is needle-free. It will target adolescents in the age group of 12-17 years.
Check ZyCoV-D three-dose vaccine efficacy, availability, price and use.
Zydus Cadila Needle-Free Vaccine
Unlike any other Covid-19 Vaccines, Zydus Cadila is the first vaccine that is needle-free. Also, this vaccine is also commonly named as ZyCov D. It is a three-dose vaccine that is for the above 12 age group.
The MD of Zydus Cadila Company reportedly announced all the details of the Needle-Free vaccine ZyCov D recently. He also told that the company is aiming to manufacture around 1 crore doses by the month of October. Apparently, a huge number of the population is still not vaccinated and the majority of them are adolescents in the age of 12-17 years. With this, all the children of the age group from 12 to 17 will get vaccinated.
ZyCov D Vaccine Price
The final Price for vaccine has not been disclosed yet as ZyCov-D 3 Dose Vaccine for Covid 19 is now in the last phase. But it is expected to be in the same price range as other vaccines in the country. The
How to Use ZyCovD Covid 19 Vaccine?
ZyCovD Covid 19 Vaccine is effective against the SARC Cov-2 virus. Any individual will have to take 3 doses at the gap of 28 days.
It is the First Plasmid DNA Vaccine and will have to be used orally.
So it is very good for the people who fear vaccination because of needles. Individuals need to have three doses of it from time to time. Read the instructions on the packet of the ZyCov-D Covid 19 vaccine before use. There can be normal symptoms after intake of ZyCovD. Make sure that you take proper precautions and doses on time.
Efficacy of Zydus Cadila ZyCovD DNA Vaccine
Zydus Cadila has reported 66 percent of the efficacy. While testing, the manufacturers found that the ZyCov D Vaccine is effective against new mutant of Corona Virus especially effective against fighting Delta covid-19 mutant.
Availability of ZyCovD Needle-Free Vaccine
The manufacturing of the ZyCov D vaccine will begin shortly as it got a nod from DCGI for emergency use. Further, more than 5 crore children from age 12 to 17 are still not vaccinated as there was no vaccination for them! However, now, after authorization of Zydus Cadila, soon by the month of October 1 crore doses will be available in markets. In the next phase, the manufacturing of doses will be multiplied in proportion to the population of children from the 12 to 17 age group.
Summary of ZyCovD Vaccine
| Name of the Vaccine | Zydus Cadila (ZyCov-D) |
| Manufacturer | Cadila Healthcare Limited |
| Trail Phase status | Three trial phases completed |
| Authorized by | DCGI (Drug Controller General of India) |
| Date of Availability | By September last week 2021 |
| Price of the Vaccine | Not announced yet |
| Age Group | Above 12 years |
| The key point of the vaccine | Needleless and DNA Plasma vaccine |
| Weblink | Zyduscadila.com |